Acupuncture in Integrated Cancer Therapy: Scientific Evidence, Clinical Appropriateness and Care Model of the Tuscan Health Service

Journal title PNEI REVIEW
Author/s Franco Cracolici
Online First 11/18/2026 Issue 2026/Online First
Language English Pages 12 P. 1-12 File size 0 KB
DOI 10.3280/pnei2026oa24174
DOI is like a bar code for intellectual property: to have more infomation click here

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

Integrated oncology represents a care model oriented towards combining conventional oncological treatments with complementary interventions selected on the basis of available evidence, safety and individual patient needs. In this context, acupuncture is one of the most studied methods for the management of neoplasia-related symptoms and adverse effects associated with surgery, chemotherapy, radiotherapy and endocrine therapies. The main areas of interest include pain, cancer-related fatigue, nausea and vomiting, chemotherapy-induced peripheral neuropathy, arthralgias associated with aromatase inhibitors, hot flashes, xerostomia, sleep disturbances and psychoemotional symptoms. Its role must be defined within supportive care and not as an alternative antineoplastic treatment. In parallel, experimental research has proposed mechanisms including neuromodulation, neurovegetative regulation, purinergic signaling, modulation of inflammatory mediators and neuro-immuno-endocrine interactions. Traditional Chinese Medicine offers a further interpretative paradigm based on the concepts of Zheng Qi, Yuan Qi and Fu Zheng; the comparison with biomedicine can generate research hypotheses, as long as unproven equivalences are avoided. Of particular interest is the experience of the Tuscan Health Service and the USL Toscana Sud Est, where integrated oncology has been progressively PNEI review – ISSNe 2532-2826 ‒ DOI: 10.3280/pnei2026oa24174 Copyright © FrancoAngeli This work is released under Creative Commons Attribution ‒ Non-Commercial – No Derivatives License. For terms and conditions of usage please see: http://creativecommons.org 2 structured through multi-professional pathways, acupuncture programs and research projects. The observational data collected in the services represent a real-world heritage of potential interest, although they require a reading consistent with the limits of uncontrolled studies.

  1. Cracolici F. (2026). “Acupuncture in integrated cancer therapy: evidence and experiences in the Tuscan health service”. Scientific and educational material unpublished.
  2. Society for Integrative Oncology (2026). SIO Practice Guidelines. Integrative Oncology. Available on-line: https://integrativeonc.org/practice-guidelines/ (accessed October 28).
  3. Mao J.J., Ismaila N., Bao T. et al. (2022). Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol., 40(34): 3998-4024.
  4. Carlson L.E., Ismaila N., Addington E.L. et al. (2023). Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults with Cancer: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol., 41(28): 4562-4591.
  5. Bower J.E., Lacchetti C., Alici Y. et al. (2024). Management of Fatigue in Adult Survivors of Cancer: ASCO-Society for Integrative Oncology Guideline Update. J Clin Oncol., 42(20): 2456-2487. DOI: 10.1200/JCO.24.00541
  6. Yeh M.L., Liao R.W., Yeh P.H., Lin C.J. & Wang Y.J. (2024). Acupuncture-related interventions im-prove chemotherapy-induced peripheral neuropathy: systematic review and network meta-analysis. BMC Complement Med Ther., 24: 310.
  7. Goldman N., Chen M., Fujita T. et al. (2010). Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci., 13(7): 883-888.
  8. de Valois, B., Young, T., Zollman, C. et al. (2024). Acupuncture in cancer care: recommendations for safe practice (peer-reviewed expert opinion). Support Care Cancer, 32: 229.
  9. Höxtermann M.D., Haller H., Jänig C. et al. (2022). Safety of acupuncture in oncology: a systematic review and meta-analysis of randomized controlled trials. Cancer., 128: 2159-2173.
  10. PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Acupuncture (PDQ®): Health Professional Version. 2024 Nov 1. In: PDQ Cancer Information Summaries [Inter-net]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389159.
  11. Demakakos P., Chrousos G.P. & Biddulph J.P. (2018). Childhood experiences of parenting and can-cer risk at older ages: findings from the English Longitudinal Study of Ageing (ELSA). Int J Public Health, 63(7): 823-832.
  12. Cole S.W., Levine M.E., Arevalo J.M.G., Ma J., Weir D.R. & Crimmins E.M. (2015). Loneliness, eu-daimonia, and the human conserved transcriptional response to adversity. Psychoneuroendocrinology, 62: 11-17.
  13. Sarma E.A., Kawachi I., Poole E.M. et al. (2018). Social integration and survival after diagnosis of colorectal cancer. Cancer., 124: 833-840.
  14. Tuscany Region. Resolution no. 418/2015: integration of complementary medicines into the Tuscan oncology network.
  15. Tuscany Region. Decree no. 2986 of 26 February 2021 and regional care pathway relating to inte-grated medicine in oncology.

Franco Cracolici, Acupuncture in Integrated Cancer Therapy: Scientific Evidence, Clinical Appropriateness and Care Model of the Tuscan Health Service in "PNEI REVIEW" Online First/2026, pp 1-12, DOI: 10.3280/pnei2026oa24174